Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft

Elvira Noviello, Guido Cimoli, Alessandro Cosimi, Enrico Allievi, Piergiorgio Galletti, Silvio Parodi, Patrizia Russo

Research output: Contribution to journalArticle

Abstract

The combination of Tumour Necrosis Factor (TNF) and mitoxantrone was evaluated for potential chemotherapeutic effect against a human ovarian cancer cell line A2774 heterotransplanted in female nude mice. Both antitumour efficacy (relative survival and reduction of ascites) and toxicity (weight loss and liver toxicity) of TNF alone, mitoxantrone alone or TNF + mitoxantrone were evaluated. A significative difference (P <0.002) was observed only among animals bearing tumours treated with mitoxantrone (0.012 mg/Kg) + TNF (5 x 105 U/Kg) and controls. No cytotoxic effects were observed for this combination. These observations provide a rationale for further evaluation of TNF + mitoxantrone based regimes for the treatment of recurrent ovarian cancer.

Original languageEnglish
Pages (from-to)330-333
Number of pages4
JournalCytokine
Volume8
Issue number4
DOIs
Publication statusPublished - Apr 1996

Keywords

  • Mitoxantrone
  • Nude mice
  • Ovarian cancer
  • Therapeutic effect
  • TNF

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Immunology
  • Immunology and Allergy

Fingerprint Dive into the research topics of 'Tumour necrosis factor enhances the therapeutic effect of mitoxantrone in human ovarian cancer xenograft'. Together they form a unique fingerprint.

Cite this